The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of ARS Pharmaceuticals Inc (NASDAQ: SPRY) was $13.31 for the day, down -5.06% from the previous closing price of $14.02. In other words, the price has decreased by -$5.06 from its previous closing price. On the day, 0.7 million shares were traded. SPRY stock price reached its highest trading level at $14.47 during the session, while it also had its lowest trading level at $13.23.
Ratios:
Our analysis of SPRY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 06 ’24 when Chakma Justin sold 50,000 shares for $14.23 per share. The transaction valued at 711,615 led to the insider holds 136,380 shares of the business.
Chakma Justin sold 49,640 shares of SPRY for $701,642 on Dec 05 ’24. The Chief Business Officer now owns 136,380 shares after completing the transaction at $14.13 per share. On Dec 04 ’24, another insider, Chakma Justin, who serves as the Chief Business Officer of the company, sold 45,000 shares for $13.95 each. As a result, the insider received 627,944 and left with 136,380 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1293539072 and an Enterprise Value of 1086978304. For the stock, the TTM Price-to-Sale (P/S) ratio is 504.04 while its Price-to-Book (P/B) ratio in mrq is 6.43. Its current Enterprise Value per Revenue stands at 423.278 whereas that against EBITDA is -17.983.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $5.01. The 50-Day Moving Average of the stock is -9.86%, while the 200-Day Moving Average is calculated to be 17.84%.
Shares Statistics:
SPRY traded an average of 1.06M shares per day over the past three months and 907190 shares per day over the past ten days. A total of 97.15M shares are outstanding, with a floating share count of 50.84M. Insiders hold about 47.68% of the company’s shares, while institutions hold 42.09% stake in the company. Shares short for SPRY as of 1731628800 were 13852113 with a Short Ratio of 13.12, compared to 1728950400 on 11915667. Therefore, it implies a Short% of Shares Outstanding of 13852113 and a Short% of Float of 26.8.
